These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3551524)

  • 41. [Endometrial estrogen and progesterone receptors in women wearing intrauterine contraceptive devices].
    Niu EM
    Zhonghua Fu Chan Ke Za Zhi; 1985 May; 20(3):160-3, 190. PubMed ID: 4017739
    [No Abstract]   [Full Text] [Related]  

  • 42. A morphometric study on the endometrial activity of women before and after one year with LNG-IUD in situ.
    Gu Z; Zhu P; Luo H; Zhu X; Zhang G; Wu S
    Contraception; 1995 Jul; 52(1):57-61. PubMed ID: 8521716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison between Nova T and Copper T 200 Ag in Hungary.
    Batar I; Lampe L; Rakoczi I; Gati I; Allonen H
    Int J Gynaecol Obstet; 1987 Feb; 25(1):59-63. PubMed ID: 2883047
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The response of endometrial blood vessels to intrauterine contraceptive devices: an electron microscopic study.
    Sheppard BL; Bonnar J
    Br J Obstet Gynaecol; 1980 Feb; 87(2):143-54. PubMed ID: 7362802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Copper determination and localization in different morphologic components of human endometrium during the menstrual cycle in copper intrauterine contraceptive device wearers.
    Salaverry G; Méndez Mdel C; Zipper J; Medel M
    Am J Obstet Gynecol; 1973 Jan; 115(2):163-8. PubMed ID: 4570954
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endometrial estradiol-17 beta-dehydrogenase activity in women wearing Cu-IUD.
    Tseng L; Dramusic V; Gurpide E
    Contraception; 1979 Mar; 19(3):247-52. PubMed ID: 455980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The menstrual cycle in women using an intrauterine device.
    Faundes A; Segal SJ; Adejuwon CA; Brache V; Leon P; Alvarez-Sanchez F
    Fertil Steril; 1980 Nov; 34(5):427-30. PubMed ID: 7439408
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Menstrual cycle stimulation in the in vitro fertilization program--effects on estrogen and progesterone receptors of the endometrium].
    Seliger E; Schöneich C; Kaltwasser P; Bergleiter R; Buchmann J; Rothe K
    Zentralbl Gynakol; 1988; 110(23):1499-506. PubMed ID: 3149099
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of combined multiload copper IUD (MLCu250 and MLCu375).
    Van Os WA; De Nooyer CC; Bakker S; Bomert L; Rhemrev PE; Loendersloot EW
    Int J Fertil; 1978; 23(2):152-5. PubMed ID: 30726
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparative study on the clinical effects and endometrial findings of IUD].
    Chao CK
    Toho Igakkai Zasshi; 1988 Mar; 34(6):550-60. PubMed ID: 12343145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
    Clark DA; Wang S; Rogers P; Vince G; Affandi B
    Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intrauterine contraception with the copper-T device. 3. Effect upon endometrial morphology.
    Hagenfeldt K; Johannisson E; Brenner P
    Contraception; 1972 Sep; 6(3):207-18. PubMed ID: 4568281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Copper as a dissociating agent of liver and endometrial polysomes.
    Hernandez O; Ballesteros LM; Domingo Mendez J; Rosado A
    Fertil Steril; 1974 Feb; 25(2):108-12. PubMed ID: 4855769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
    Shaw ST; Macaulay LK; Sun NC; Tanaka MS; Roche PC
    Contraception; 1983 Feb; 27(2):131-40. PubMed ID: 6682747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ovarian function during use of a levonorgestrel-releasing IUD.
    Barbosa I; Bakos O; Olsson SE; Odlind V; Johansson ED
    Contraception; 1990 Jul; 42(1):51-66. PubMed ID: 2117516
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of intrauterine levonorgestrel use on the expression of c-JUN, oestrogen receptors, progesterone receptors and Ki-67 in human endometrium.
    Salmi A; Pakarinen P; Peltola AM; Rutanen EM
    Mol Hum Reprod; 1998 Dec; 4(12):1110-5. PubMed ID: 9872360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices.
    Toivonen J; Luukkainen T; Allonen H
    Obstet Gynecol; 1991 Feb; 77(2):261-4. PubMed ID: 1899136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Five years' experience of intrauterine contraception with the Nova-T and the Copper-T-200.
    Luukkainen T; Allonen H; Nielsen NC; Nygren KG; Pyörälä T
    Am J Obstet Gynecol; 1983 Dec; 147(8):885-92. PubMed ID: 6650625
    [TBL] [Abstract][Full Text] [Related]  

  • 60. No increase of the fibrinolytic activity of the human endometrium by progesterone-releasing IUD (ProgestasertR).
    Liedholm P; Sjöberg NO; Srivastava K; Astedt B
    Contraception; 1978 Jun; 17(6):531-6. PubMed ID: 720058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.